Drug Type siRNA |
Synonyms ADX 626, ADX626 |
Target |
Action inhibitors |
Mechanism F11 inhibitors(Coagulation factor XI inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |

| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Thrombosis | Preclinical | United States | 01 Jan 2025 |





